| abstract |
The invention discloses a pharmaceutical composition, which comprises: 100 parts of subprostrate sophora flavonoid extract, 5-10 parts of baicalin, 5-10 parts of fibrauretine and 5-10 parts of geniposide. The pharmaceutical composition can inhibit the secretion of inflammatory factors TNF-alpha and IL-6 on one hand, promote the secretion of antiviral factors IFN-gamma on the other hand, finally reduce inflammatory injury and relieve lung tissue injury caused by virus infection, has better treatment effect when the addition amount of the pharmaceutical composition is not less than 5 mg/kg.d, and provides a new idea for treating viral pneumonia. |